bpc-157 safety studies human The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity 10 questions to ask your

For acute injuries, split dosing (half the daily amount every 12 hours) maintains more consistent tissue levels

Inspired by the Irish word Tura Beatha (pronounced Ba-ha) meaning journey of life our mission is to help you navigate the road ahead with confidence

Important context: These peptides are still NOT FDA-approved But they can now move through formal regulatory review Compounding access may expand again through licensed providers Whats next: July 2026: Formal review begins Late 2026+: Potential decisions on access and compounding pathways For the past two years, limited access pushed demand into unregulated markets

The April 2024 landmark paper proposing BPC-157 as a cytoprotection mediator with neurotransmitter-like activity provides an elegant theoretical framework, but elegance is not evidence

Rooted in Valengerontology the science of building health, not just treating disease

However, results from animal experiments cannot be extrapolated to clinical settings